Merck posts loss due to Vioxx settlement
TRENTON, N.J. - Merck & Co. on Tuesday posted a $1.63 billion loss in the fourth quarter as whopping charges, mainly for its Vioxx litigation settlement, dragged down results. The maker of allergy and asthma pill Singulair and osteoporosis treatment …